loading page

PROLONGED COVID-19 INFECTION IN A CHILD WITH LYMPHOBLASTIC NON HODGKIN LYMPHOMA: WHICH IS THE BEST MANAGEMENT?
  • +13
  • Giovanna Gattuso,
  • Elisabetta Schiavello,
  • Chiara Oltolini,
  • Veronica Biassoni,
  • Monica Terenziani,
  • Stefano Chiaravalli,
  • Marta Podda,
  • Cristina Meazza,
  • Roberto Luksch,
  • Andrea Ferrari,
  • Michela Casanova,
  • Giovanna Sironi,
  • Luca Bergamaschi,
  • Nadia Puma,
  • Filippo Spreafico,
  • Maura Massimino
Giovanna Gattuso
Fondazione IRCCS Istituto Nazionale dei Tumori

Corresponding Author:giovanna.gattuso@istitutotumori.mi.it

Author Profile
Elisabetta Schiavello
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Chiara Oltolini
San Raffaele Hospital
Author Profile
Veronica Biassoni
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Monica Terenziani
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Stefano Chiaravalli
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Marta Podda
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Cristina Meazza
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Roberto Luksch
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Andrea Ferrari
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Michela Casanova
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Giovanna Sironi
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Luca Bergamaschi
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Nadia Puma
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Filippo Spreafico
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile
Maura Massimino
Fondazione IRCCS Istituto Nazionale dei Tumori
Author Profile

Abstract

During SARS-CoV-2 pandemic, oncologists manage patients at higher risk of having a severe course of this infection. This raises new questions about their correct management, as well as the difficulty of distinguishing tumor/treatments complications from those related to Coronavirus disease 2019 (COVID-19). We report a case of an 11 year-old boy undergoing treatment for T cell lymphoblastic lymphoma who experienced a prolonged SARS-CoV-2 infection. Oncological therapy was continued without significant changes compared to the initially planned treatment. No relevant complications occurred. COVID-19 convalescent plasma (CP) was administered, resulting in a positive antibody titer after 24 days.